Drug comparisons
Canagliflozin vs Acetohexamide
Canagliflozin vs Acetohexamide for type 2 diabetes. Modern SGLT2 inhibitor compared to older sulfonylurea regarding efficacy and hypoglycemia risk.
No comparison dimensions are available for this page.
Clinical context
This comparison occurs when evaluating a current SGLT2 inhibitor against an older first-generation sulfonylurea for type 2 diabetes therapy.
Bottom line
Canagliflozin is typically preferred over Acetohexamide for most patients with type 2 diabetes based on safety and extra benefits.
All medication comparisons